lanonc.gif

Hematology

The Lancet Oncology

Editor in Chief: David Collingridge, PhD

The Lancet Oncology, published monthly, provides oncology-related specialists something truly rare and valuable—definitive coverage of all aspects of oncology from around the world—in a single, highly readable source.

The aim of The Lancet Oncology is to publish interesting and informative research on any topic connected with oncology. The journal's great reputation and high profile allowed it to extend into the field of primary research from May 2005.

For our advertisers, this high profile journal provides an excellent platform from which to advertise your products and services relevant to the oncology professional. We are confident that The Lancet Oncology is the first place oncology related specialists look when investigating well-respected opinion, news and reviews, or the latest in important clinical trials. 

Global Print Circulation
16,000
Avg. Global Monthly Visits
207,554
Avg. Global Monthly Unique Visitors
153,310
Avg. Global Monthly Page Views
327,193
Avg. Global eTOC Distribution
117,036
Circulation updated on 1st July, 2024, based on 12-month monthly average July 2023-June 2024, eTOC Metrics: 12 Month Average of eTOC sends - July 2023 to June 2024, Monthly average web metrics based on the period of July 2023 to June 2024

Rate Card

Find the best value for your advertising dollars

Journal Website

Find out more directly from the source

Journal Metrics

Detailed insights into the reach and penetration of this journal

Contacts

Elsevier

Circle Placeholder
Elsevier Inbound Sales

Email : journalmedia@elsevier.com